Alkeus Pharmaceuticals Competitors and Similar CompaniesClear all
Alkeus Pharmaceuticals's competitors and similar companies include Eyevance Pharmaceuticals, Genentech, Biogen and Fujifilm Diosynth Biotechnologies.
 Alkeus Pharmaceuticals Alkeus Pharmaceuticals is a biopharmaceutical company focused on discovering and developing treatments against serious and untreatable diseases of the eye. |  Eyevance Pharmaceuticals Eyevance Pharmaceuticals is a company that develops ophthalmic therapies for the ocular surface and anterior segment. |  Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines. |  Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. |  Fujifilm Diosynth Biotechnologies Fujifilm Diosynth Biotechnologies U.S.A. is a contract development and manufacturing organization operating in the biopharmaceutical industry. | |
Founding Date | Founding Date 2011 | Founding Date 2017 | Founding Date 1976 | Founding Date 1978 | Founding Date 2011 |
Type | Type Private | Type Private | Type Subsidiary | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Somerville, US HQ | Locations Fort Worth, US HQ Fort Worth, US | Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more | Locations Morrisville, US HQ Hillerød, DK Stockton On Tees, GB College Station, US |
Employees | Employees 2 | Employees 3716% decrease | Employees 18,077 | Employees 7,605 | Employees 5,3942% increase |
Operating ⚠ | |||||
Phase I Trials Products | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products 28 (Jul, 2025) | Phase I Trials Products 4 (FY, 2024) | Phase I Trials Products N/A |
Phase II Trials Products | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products 19 (Jul, 2025) | Phase II Trials Products 6 (FY, 2024) | Phase II Trials Products N/A |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products 41 (Jul, 2025) | Phase III Trials Products 11 (FY, 2024) | Phase III Trials Products N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 30k | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 850m |
For sources of this data, please see the company profile
View Company Profiles
Eyevance Pharmaceuticals
HQ
Fort Worth, US
Employees
37↓ 16% decrease
Eyevance Pharmaceuticals is a company that develops ophthalmic therapies for the ocular surface and anterior segment.
View companyGenentech
HQ
South San Francisco, US
Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
View companyBiogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View companyFujifilm Diosynth Biotechnologies
HQ
Morrisville, US
Fujifilm Diosynth Biotechnologies U.S.A. is a contract development and manufacturing organization operating in the biopharmaceutical industry.
View company